Capricor Therapeutics's total assets for Q1 2024 were $49.44M, a decrease of -15.82% from the previous quarter. CAPR total liabilities were $31.01M for the fiscal quarter, a -14.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.